DE602007003841D1 - Blockcopolymere mit einem methoxyethylmethacrylat-mittelblock - Google Patents

Blockcopolymere mit einem methoxyethylmethacrylat-mittelblock

Info

Publication number
DE602007003841D1
DE602007003841D1 DE602007003841T DE602007003841T DE602007003841D1 DE 602007003841 D1 DE602007003841 D1 DE 602007003841D1 DE 602007003841 T DE602007003841 T DE 602007003841T DE 602007003841 T DE602007003841 T DE 602007003841T DE 602007003841 D1 DE602007003841 D1 DE 602007003841D1
Authority
DE
Germany
Prior art keywords
mittelblock
methoxyethylmethacrylat
mit einem
blockcopolymere
blockcopolymere mit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007003841T
Other languages
English (en)
Inventor
Thierry Glauser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Cardiovascular Systems Inc
Original Assignee
Abbott Cardiovascular Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Cardiovascular Systems Inc filed Critical Abbott Cardiovascular Systems Inc
Publication of DE602007003841D1 publication Critical patent/DE602007003841D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F293/00—Macromolecular compounds obtained by polymerisation on to a macromolecule having groups capable of inducing the formation of new polymer chains bound exclusively at one or both ends of the starting macromolecule
    • C08F293/005—Macromolecular compounds obtained by polymerisation on to a macromolecule having groups capable of inducing the formation of new polymer chains bound exclusively at one or both ends of the starting macromolecule using free radical "living" or "controlled" polymerisation, e.g. using a complexing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/148—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D153/00—Coating compositions based on block copolymers containing at least one sequence of a polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds; Coating compositions based on derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Materials Engineering (AREA)
  • Wood Science & Technology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Graft Or Block Polymers (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Prostheses (AREA)
DE602007003841T 2006-06-29 2007-06-29 Blockcopolymere mit einem methoxyethylmethacrylat-mittelblock Active DE602007003841D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/480,023 US8956640B2 (en) 2006-06-29 2006-06-29 Block copolymers including a methoxyethyl methacrylate midblock
PCT/US2007/015097 WO2008005317A1 (en) 2006-06-29 2007-06-29 Block copolymers including a methoxyethyl methacrylate midblock

Publications (1)

Publication Number Publication Date
DE602007003841D1 true DE602007003841D1 (en) 2010-01-28

Family

ID=38665467

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007003841T Active DE602007003841D1 (en) 2006-06-29 2007-06-29 Blockcopolymere mit einem methoxyethylmethacrylat-mittelblock

Country Status (6)

Country Link
US (1) US8956640B2 (de)
EP (1) EP2038319B1 (de)
JP (1) JP5201486B2 (de)
AT (1) ATE452152T1 (de)
DE (1) DE602007003841D1 (de)
WO (1) WO2008005317A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7700819B2 (en) 2001-02-16 2010-04-20 Kci Licensing, Inc. Biocompatible wound dressing
US7763769B2 (en) 2001-02-16 2010-07-27 Kci Licensing, Inc. Biocompatible wound dressing
US8293318B1 (en) 2006-08-29 2012-10-23 Abbott Cardiovascular Systems Inc. Methods for modulating the release rate of a drug-coated stent
US8562669B2 (en) * 2008-06-26 2013-10-22 Abbott Cardiovascular Systems Inc. Methods of application of coatings composed of hydrophobic, high glass transition polymers with tunable drug release rates
EP2189846B1 (de) * 2008-11-19 2015-04-22 Rohm and Haas Electronic Materials LLC Verfahren für die Fotolithographie unter Verwendung einer Fotolackzusammensetzung beinhaltend ein Blockcopolymer
JP6833673B2 (ja) * 2015-03-10 2021-02-24 国立大学法人山形大学 抗血栓性ブロック共重合体

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6387379B1 (en) * 1987-04-10 2002-05-14 University Of Florida Biofunctional surface modified ocular implants, surgical instruments, medical devices, prostheses, contact lenses and the like
US5019096A (en) * 1988-02-11 1991-05-28 Trustees Of Columbia University In The City Of New York Infection-resistant compositions, medical devices and surfaces and methods for preparing and using same
US4931287A (en) * 1988-06-14 1990-06-05 University Of Utah Heterogeneous interpenetrating polymer networks for the controlled release of drugs
US6117176A (en) * 1993-11-15 2000-09-12 Applied Elastomerics, Inc. Elastic-crystal gel
US5163952A (en) * 1990-09-14 1992-11-17 Michael Froix Expandable polymeric stent with memory and delivery apparatus and method
US6248129B1 (en) * 1990-09-14 2001-06-19 Quanam Medical Corporation Expandable polymeric stent with memory and delivery apparatus and method
US5258020A (en) * 1990-09-14 1993-11-02 Michael Froix Method of using expandable polymeric stent with memory
DE69227818T2 (de) * 1991-09-27 1999-06-02 Fuji Photo Film Co Ltd Elektrophotographisches Material zur Farbprüfung
US5219945A (en) * 1992-02-20 1993-06-15 E. I. Du Pont De Nemours And Company ABC triblock methacrylate polymers
JPH0818950B2 (ja) * 1992-05-01 1996-02-28 花王株式会社 化粧料
KR960015447B1 (ko) * 1993-03-16 1996-11-14 주식회사 삼양사 의료용 생분해성 고분자
CA2190121A1 (en) * 1994-03-15 1995-09-21 Edith Mathiowitz Polymeric gene delivery system
ATE198979T1 (de) * 1994-10-12 2001-02-15 Focal Inc Zielgerichte verabreichung mittels biologisch abbaubarer polymere
US6179817B1 (en) * 1995-02-22 2001-01-30 Boston Scientific Corporation Hybrid coating for medical devices
US5869127A (en) * 1995-02-22 1999-02-09 Boston Scientific Corporation Method of providing a substrate with a bio-active/biocompatible coating
US5674242A (en) * 1995-06-06 1997-10-07 Quanam Medical Corporation Endoprosthetic device with therapeutic compound
US7611533B2 (en) * 1995-06-07 2009-11-03 Cook Incorporated Coated implantable medical device
US5609629A (en) * 1995-06-07 1997-03-11 Med Institute, Inc. Coated implantable medical device
AU716005B2 (en) * 1995-06-07 2000-02-17 Cook Medical Technologies Llc Implantable medical device
US7550005B2 (en) * 1995-06-07 2009-06-23 Cook Incorporated Coated implantable medical device
US5723219A (en) * 1995-12-19 1998-03-03 Talison Research Plasma deposited film networks
US5932299A (en) * 1996-04-23 1999-08-03 Katoot; Mohammad W. Method for modifying the surface of an object
US6530951B1 (en) * 1996-10-24 2003-03-11 Cook Incorporated Silver implantable medical device
US5997517A (en) * 1997-01-27 1999-12-07 Sts Biopolymers, Inc. Bonding layers for medical device surface coatings
US6159978A (en) * 1997-05-28 2000-12-12 Aventis Pharmaceuticals Product, Inc. Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
US6180632B1 (en) * 1997-05-28 2001-01-30 Aventis Pharmaceuticals Products Inc. Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
US6245760B1 (en) * 1997-05-28 2001-06-12 Aventis Pharmaceuticals Products, Inc Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
WO1998057671A2 (en) * 1997-06-18 1998-12-23 Boston Scientific Corporation Polycarbonate-polyurethane dispersions for thrombo-resistant coatings
US6110483A (en) * 1997-06-23 2000-08-29 Sts Biopolymers, Inc. Adherent, flexible hydrogel and medicated coatings
US6258371B1 (en) * 1998-04-03 2001-07-10 Medtronic Inc Method for making biocompatible medical article
US20030040790A1 (en) * 1998-04-15 2003-02-27 Furst Joseph G. Stent coating
US20010029351A1 (en) * 1998-04-16 2001-10-11 Robert Falotico Drug combinations and delivery devices for the prevention and treatment of vascular disease
US20020188037A1 (en) 1999-04-15 2002-12-12 Chudzik Stephen J. Method and system for providing bioactive agent release coating
ATE219693T1 (de) * 1998-04-27 2002-07-15 Surmodics Inc Bioaktive wirkstoffe freisetzende beschichtungen
US6299604B1 (en) * 1998-08-20 2001-10-09 Cook Incorporated Coated implantable medical device
US6187024B1 (en) * 1998-11-10 2001-02-13 Target Therapeutics, Inc. Bioactive coating for vaso-occlusive devices
US6451972B1 (en) * 1998-11-16 2002-09-17 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Peptido-mimetic compounds containing RGD sequence useful as integrin inhibitors
US6530950B1 (en) * 1999-01-12 2003-03-11 Quanam Medical Corporation Intraluminal stent having coaxial polymer member
US6143354A (en) * 1999-02-08 2000-11-07 Medtronic Inc. One-step method for attachment of biomolecules to substrate surfaces
US6790228B2 (en) * 1999-12-23 2004-09-14 Advanced Cardiovascular Systems, Inc. Coating for implantable devices and a method of forming the same
US6613432B2 (en) * 1999-12-22 2003-09-02 Biosurface Engineering Technologies, Inc. Plasma-deposited coatings, devices and methods
WO2001047572A2 (en) * 1999-12-29 2001-07-05 Advanced Cardiovascular Systems, Inc. Device and active component for inhibiting formation of thrombus-inflammatory cell matrix
EP1275670B1 (de) 2000-01-21 2005-08-10 Mitsui Chemicals, Inc. Olefinblockcopolymere, herstellungsverfahren derselben und ihre anwendung
WO2001079315A1 (en) * 2000-04-18 2001-10-25 Clemson University Polylactide/dextran graft co-polymers for biomaterial and tissue engineering applications
US20020007214A1 (en) * 2000-05-19 2002-01-17 Robert Falotico Drug/drug delivery systems for the prevention and treatment of vascular disease
US20020007215A1 (en) * 2000-05-19 2002-01-17 Robert Falotico Drug/drug delivery systems for the prevention and treatment of vascular disease
US20020005206A1 (en) * 2000-05-19 2002-01-17 Robert Falotico Antiproliferative drug and delivery device
US20020007213A1 (en) * 2000-05-19 2002-01-17 Robert Falotico Drug/drug delivery systems for the prevention and treatment of vascular disease
US6776796B2 (en) * 2000-05-12 2004-08-17 Cordis Corportation Antiinflammatory drug and delivery device
US6306423B1 (en) * 2000-06-02 2001-10-23 Allergan Sales, Inc. Neurotoxin implant
DE60124941T2 (de) * 2000-09-28 2007-07-12 KURARAY CO., LTD, Kurashiki Blockcopolymer
US20020051730A1 (en) * 2000-09-29 2002-05-02 Stanko Bodnar Coated medical devices and sterilization thereof
US20020111590A1 (en) * 2000-09-29 2002-08-15 Davila Luis A. Medical devices, drug coatings and methods for maintaining the drug coatings thereon
US7261735B2 (en) * 2001-05-07 2007-08-28 Cordis Corporation Local drug delivery devices and methods for maintaining the drug coatings thereon
US6545097B2 (en) 2000-12-12 2003-04-08 Scimed Life Systems, Inc. Drug delivery compositions and medical devices containing block copolymer
US7077859B2 (en) * 2000-12-22 2006-07-18 Avantec Vascular Corporation Apparatus and methods for variably controlled substance delivery from implanted prostheses
US20020082679A1 (en) * 2000-12-22 2002-06-27 Avantec Vascular Corporation Delivery or therapeutic capable agents
US6663662B2 (en) * 2000-12-28 2003-12-16 Advanced Cardiovascular Systems, Inc. Diffusion barrier layer for implantable devices
EP1463438A4 (de) * 2001-02-09 2008-01-23 Endoluminal Therapeutics Inc Endomurale therapie
WO2002072014A2 (en) * 2001-03-08 2002-09-19 Volcano Therapeutics, Inc. Medical devices, compositions and methods for treating vulnerable plaque
EP2283845A1 (de) * 2001-04-26 2011-02-16 pSivida Inc. Retardformulierung mit konjugierten Wirkstoffen
US7247313B2 (en) * 2001-06-27 2007-07-24 Advanced Cardiovascular Systems, Inc. Polyacrylates coatings for implantable medical devices
JP2005504813A (ja) * 2001-09-24 2005-02-17 メドトロニック・エイヴイイー・インコーポレーテッド 合理的薬剤療法デバイス及び方法
US7195640B2 (en) * 2001-09-25 2007-03-27 Cordis Corporation Coated medical devices for the treatment of vulnerable plaque
US20030065377A1 (en) * 2001-09-28 2003-04-03 Davila Luis A. Coated medical devices
US6939376B2 (en) * 2001-11-05 2005-09-06 Sun Biomedical, Ltd. Drug-delivery endovascular stent and method for treating restenosis
WO2003068836A1 (fr) 2002-02-13 2003-08-21 Kaneka Corporation Copolymere sequence
JP4081283B2 (ja) 2002-03-04 2008-04-23 株式会社カネカ ブロック共重合体の製法
US7005137B1 (en) * 2002-06-21 2006-02-28 Advanceed Cardiovascular Systems, Inc. Coating for implantable medical devices
AU2003277538A1 (en) * 2002-11-06 2004-06-07 Kuraray Co., Ltd. Thermoplastic polymer powder
US7094256B1 (en) * 2002-12-16 2006-08-22 Advanced Cardiovascular Systems, Inc. Coatings for implantable medical device containing polycationic peptides
US8388677B2 (en) * 2004-10-29 2013-03-05 Boston Scientific Scimed, Inc. Anti-thrombogenic and anti-restenotic vascular medical devices
EP1655354B1 (de) * 2004-11-09 2013-10-23 JSR Corporation Beschichtungszusammensetzung zur Absorptionsverhinderung einer biologischen Substanz, damit überzogener Gegenstand und Verfahren zu deren Verwendung

Also Published As

Publication number Publication date
US20080003253A1 (en) 2008-01-03
JP2009542335A (ja) 2009-12-03
US8956640B2 (en) 2015-02-17
ATE452152T1 (de) 2010-01-15
EP2038319B1 (de) 2009-12-16
EP2038319A1 (de) 2009-03-25
JP5201486B2 (ja) 2013-06-05
WO2008005317A1 (en) 2008-01-10

Similar Documents

Publication Publication Date Title
DE602007003841D1 (en) Blockcopolymere mit einem methoxyethylmethacrylat-mittelblock
PL1906939T3 (pl) Zastosowanie częściowo zobojętnianego, anionowego kopolimeru (met)akrylanowego jako powłoki do wytwarzania postaci leku z uwalnianiem substancji czynnej przy obniżonych wartościach pH
HK1203421A1 (en) Flat process of drug coating of stents
EP1985283A4 (de) Gelbildende zusammensetzung zur verwendung in der medizin, vorrichtungen zur anwendung der zusammensetzung und arzneimittelfreisetzungssteuerträger
PT2004033T (pt) Dispositivo para irrigação de cavidades corporais
HK1129558A1 (en) An aneurysm occlusion device
ZA200903337B (en) An automatic miniature injector and sample-taker device for medical use
WO2007145961A3 (en) Microporous coating on medical devices
MX2009003439A (es) Aplicador para un dispositivo para la incontinencia urinaria.
EP2012697A4 (de) Vorrichtung zur anwendung bei der transluminalen und endoluminalen chirurgie
GB0603481D0 (en) Slow release agent absorbent dressing
EP2060264A4 (de) Mittel zur behandlung von augenerkrankungen
EP1741441A4 (de) Durch verwendung eines cathepsin-k-hemmers mit pth gekennzeichnetes knochenverdichtungsmittel
HK1206262A1 (en) Implants for the treatment of dopamine associated states
GB0603482D0 (en) Three-dimensional slow release agent absorbent dressing
HK1258466A1 (zh) Mmp活化血管破壞劑
EP2066304A4 (de) Systeme, verfahren und zusammensetzungen zur behandlung und verwendung eines gaumenpflasters
EP2124817A4 (de) Bioabsorbierbare beschichtungen für medizinische vorrichtungen
EP2211985A4 (de) Vorrichtung zur behandlung eines aneurysmas
EP2018134A4 (de) Vorrichtung zur einführung eines künstlichen blutgefässstents
HK1136773A1 (en) Treatment of multiple sclerosis (ms) with campath-1h
EP2100627A4 (de) (meth)acrylat-copolymer, verfahren zu seiner herstellung und medizinprodukt
ZA200904478B (en) Novel therapeutic use for treating leukaemia
GB2443716B8 (en) Copolymers suitable for use in corneal bandages
EP2068789A4 (de) Vorrichtung zur änderung der körpertemperatur eines patienten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition